Immunogenicity and safety of single-dose, 13-valent pneumococcal conjugate vaccine in pediatric and adolescent oncology patients-Reference-Cited by-同舟云学术

Immunogenicity and safety of single-dose, 13-valent pneumococcal conjugate vaccine in pediatric and adolescent oncology patients

Published:2017-07-11 Issue:21 Volume:123 Page:4215-4223
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Hung Te-Yu¹²^ORCID,Kotecha Rishi S.¹²³^ORCID,Blyth Christopher C.²³⁴⁵,Steed Sarah K.¹,Thornton Ruth B.²³,Ryan Anne L.¹,Cole Catherine H.¹²³⁴,Richmond Peter C.²³⁶

Affiliation:

1. Department of Haematology and Oncology; Princess Margaret Hospital for Children; Perth Western Australia Australia

2. School of Paediatrics and Child Health; University of Western Australia; Perth Western Australia Australia

3. Telethon Kids Institute; University of Western Australia; Perth Western Australia Australia

4. PathWest Laboratory Medicine WA; Perth Western Australia Australia

5. Department of Infectious Diseases; Princess Margaret Hospital for Children; Perth Western Australia Australia

6. Department of Paediatrics; Princess Margaret Hospital for Children; Perth Western Australia Australia

Funder

Perth Children's Hospital Foundation

Princess Margaret Hospital Foundation

Telethon Research Fellowship

West Australia Department of Health/Raine Early Career Research Fellowship

National Health and Medical Research Counsel Career Development Fellowship

BrightSpark Foundation Fellowship

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference25 articles.

1. Impaired pneumococcal immunity in children after treatment for acute lymphoblastic leukaemia;Lehrnbecher;Br J Haematol.,2009

2. Serotype-specific pneumococcal antibody concentrations in children treated for acute leukaemia;Patel;Arch Dis Child.,2012

3. Risks of invasive pneumococcal disease in children with underlying chronic diseases;Hjuler;Pediatrics.,2008

4. Increased risk for invasive pneumococcal diseases in children with acute lymphoblastic leukaemia;Meisel;Br J Haematol.,2007

5. The changing epidemiology of invasive pneumococcal disease in aboriginal and non-aboriginal western Australians from 1997 through 2007 and emergence of nonvaccine serotypes;Lehmann;Clin Infect Dis.,2010

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing Immune Response in Non-Small-Cell Lung Cancer Patients: Impact of the 13-Valent Pneumococcal Conjugate Vaccine;Journal of Clinical Medicine;2024-03-06

2. Multiplexed suspension array immunoassays for detection of antibodies to pneumococcal polysaccharide and conjugate vaccines;Frontiers in Cellular and Infection Microbiology;2023-11-15

3. Vaccinations in children with hematologic malignancies and those receiving hematopoietic stem cell transplants or cellular therapies;Transplant Infectious Disease;2023-07-12

4. Vacunación en cáncer infantil: revisión de alcance;Gaceta Mexicana de Oncolog�a;2023-06-30

5. Reducedhumoral response against variants of concern in childhood solid cancer patients compared to adult patients and healthy children after SARS-CoV-2 vaccination;Frontiers in Immunology;2023-05-25